Clinical Trial Update: Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring an insulin-sensitizing medication added to depression treatment in individuals who are depressed and overweight.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Washington University School of Medicine | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2018-02-28